Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroprocaine 3% gel eye drops in healthy volunteers
2020-000465-17Phase 2Completed
- Sponsor
- Sintetica
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in None and procedural pain comparing Chloroprocaine 3% ophthalmic gel with Vehicle control ophthalmic gel (2 arms). Primary endpoint: Full ocular surface anesthesia at 5 minutes. Started Mar 2020; status: completed.
02
Drugs
chloroprocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on 2020-000465-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000465-17.